Loading clinical trials...

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 4NCT00199004

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

The study evaluates the efficacy and tolerability of an intensified induction and consolidation therapy in combination with rituximab in CD20 positive standard risk patients. Thereafter patients recei...

Lead sponsor: Johann Wolfgang Goethe University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETEDPhase 4

German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT00198978 · Adult Acute Lymphocytic Leukemia

COMPLETEDPhase 3

Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma

NCT00199043 · Adult Acute Lymphocytic Leukemia, High-grade Lymphoma

COMPLETEDPhase 4

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

NCT00198991 · Adult Acute Lymphocytic Leukemia

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 23, 2010Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment60

Start dateApr 2004

Last updatedAug 23, 2010

Condition

Adult Acute Lymphocytic Leukemia

Locations shown

University Hospital of Frankfurt, Medical Dept. II

Frankfurt

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 23, 2010Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions